Search Results 331-340 of 7764 for SC

  1. Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY) - Mayo Clinic

    The purpose of this multinational, randomized, placebo-controlled, and double blind study is to evaluate the safety and efficacy of subcutaneous (SC) ...

  2. Alumni - Spine Surgery Fellowship (Minnesota) - Mayo Clinic College of Medicine & Science

    Alumni · Testimonial videos · Adan Omar, M.D. · Benjamin Streufert, M.D. · Sandra Hobson, M.D. · Jad Bou Monsef, M.D. · Alumni spotlight · Ilyas Aleem, M.D., M.Sc.

  3. Publications - Natally Horvat , M.D., Ph.D. - Mayo Clinic

    ... SC. Magnifying chromoendoscopy is a reliable method in the selection of ... SC, Gollub MJ, Horvat N. Mucinous Degeneration on MRI After Neoadjuvant ...

  4. Meet Our Fellows - Abdominal Transplant Surgery Fellowship (Arizona) - Mayo Clinic College of Medicine & Science

    Ananth Srinivasan, M.D., 2019, Staff Transplant Surgeon, INTEGRIS Nazih Zuhdi Transplant Institute. Emmanouil Giorgakis, M.D., M.Sc. 2018, Assistant Professor ...

  5. Epigenomics and Spatial Biology Core - Mayo Clinic Research

    Single cell (sc) ATAC-seq. Single-cell ATAC-seq combined with gene expression (scATAC+GEX). Single-cell GEX Flex, a single-cell transcriptome assay for ...

  6. Spinal cord injury - Symptoms and causes - Mayo Clinic

    It also can include damage to nerves at the end of the spinal cord, known as the cauda equina. The spinal cord sends and receives signals between the brain and ...

  7. A Phase 3 Study to Examine the Effectiveness, Safety and Tolerability of APL-130277 for the Acute Treatment of Motor Fluctuation Episodes in Patients with Parkinson's Disease - Mayo Clinic

    continuous s.c. apomorphine infusion; or Duodopa/Duopa. Treatment with any form of s.c. apomorphine within 7 days prior to the initial screening visit (SV1).

  8. A Study to Evaluate the Safety and Effectiveness of Gantenerumab in Participants With Early Alzheimer's Disease (AD) - Mayo Clinic

    Eligible participants will be randomized 1:1 to receive either subcutaneous (SC) injection of gantenerumab or placebo. The primary efficacy assessment will ...

  9. A Study to Examine the Long-Term Safety, Tolerability and Effectiveness of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients with Parkinson's Disease - Mayo Clinic

    Treatment with any form of s.c. apomorphine within 7 days prior to the initial Screening Visit (SV1). Patients that stopped s.c. apomorphine for any reason ...

  10. Publications - John A. Occhino, M.D., M.S. - Mayo Clinic

    ... SC, Pasupathy KS. Vaginal Hysterectomy: Historical Footnote or Viable Route ... SC, Pasupathy KS, Gebhart JB. Prospective Implementation and Evaluation ...